MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2004; 63:11-30; PMID:23335087; http://dx.doi.org/10.3322/caac.21166
   Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Wang L, Shi ZM, Jiang CF, Liu X, Chen QD, Qian X, Li DM, Ge X, Wang XF, Liu LZ, et al. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Oncotarget 2014; 5:5416-27; PMID:24980823; http://dx.doi.org/10.18632/oncotarget.2116
   PubMed Web of Science ®Google Scholar
• Farhana L, Dawson MI, Fontana JA. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells. Cancer Biol Ther 2015; 16:115-24; PMID:25611699; http://dx.doi.org/10.4161/15384047.2014.987070
   PubMed Web of Science ®Google Scholar
• Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010; 79:313-20; PMID:21412018; http://dx.doi.org/10.1159/000323283
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34:D140-4; PMID:16381832; http://dx.doi.org/10.1093/nar/gkj112
   PubMed Web of Science ®Google Scholar
• Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010; 116:e118-27; PMID:20733160; http://dx.doi.org/10.1182/blood-2010-05-285403
   PubMed Web of Science ®Google Scholar
• Zhang L, Qian J, Qiang Y, Huang H, Wang C, Li D, Xu B. Down-regulation of miR-4500 promoted non-small cell lung cancer growth. Cell Physiol Biochem 2014; 34:1166-74; PMID:25277326; http://dx.doi.org/10.1159/000366329
   PubMed Web of Science ®Google Scholar
• Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautière P, Cary P, Crane-Robinson C, Coles B, Goodwin GH. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 1991; 19:6793-7; PMID:1762909; http://dx.doi.org/10.1093/nar/19.24.6793
   PubMed Web of Science ®Google Scholar
• Wang X, Liu X, Li AY, Chen L, Lai L, Lin HH, Hu S, Yao L, Peng J, Loera S, et al. Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin Cancer Res 2011; 17:2570-80; PMID:21252160; http://dx.doi.org/10.1158/1078-0432.CCR-10-2542
   PubMed Web of Science ®Google Scholar
• Wood LJ, Maher JF, Bunton TE, Resar LM. The oncogenic properties of the HMG-I gene family. Cancer Res 2000; 60:4256-61; PMID:10945639
   PubMed Web of Science ®Google Scholar
• Zhou H, Guo W, Zhao Y, Wang Y, Zha R, Ding J, Liang L, Hu J, Shen H, Chen Z, et al. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2. Int J Oncol 2014; 44:2050-8; PMID:24682444; http://dx.doi.org/10.3892/ijo.2014.2360
   PubMed Web of Science ®Google Scholar
• Malek A, Bakhidze E, Noske A, Sers C, Aigner A, Schäfer R, Tchernitsa O. HMGA2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer 2008; 23:348-56; http://dx.doi.org/10.1002/ijc.23491
   Web of Science ®Google Scholar
• Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett 2014; 355:130-40; PMID:25218351; http://dx.doi.org/10.1016/j.canlet.2014.09.007
   PubMed Web of Science ®Google Scholar
• Yang GL, Zhang LH, Bo JJ, Hou KL, Cai X, Chen YY, Li H, Liu DM, Huang YR. Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer. Eur J Surg Oncol 2011; 37:265-71; PMID:21273026; http://dx.doi.org/10.1016/j.ejso.2011.01.004
   PubMed Web of Science ®Google Scholar
• Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, Zimmermann A, Diamantis I, Terracciano L, Fusco A, Karamitopoulou E. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology 2012; 60:397-404; PMID:22276603; http://dx.doi.org/10.1111/j.1365-2559.2011.04121.x
   PubMed Web of Science ®Google Scholar
• Califano D, Pignata S, Losito NS, Ottaiano A, Greggi S, De Simone V, Cecere S, Aiello C, Esposito F, Fusco A, et al. High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer. J Cell Physiol 2014; 229:53-9; PMID:23765903; http://dx.doi.org/10.1002/jcp.24416
   PubMed Web of Science ®Google Scholar
• Wu ZY, Wang SM, Chen ZH, Huv SX, Huang K, Huang BJ, Du JL, Huang CM, Peng L, Jian ZX, et al. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer. Cancer Biomark 2015; 15:535-42; PMID:26406941; http://dx.doi.org/10.3233/CBM-150492
   PubMed Web of Science ®Google Scholar
• Kim TH, Song JY, Park H, Jeong JY, Kwon AY, Heo JH, Kang H, Kim G, An HJ. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. Cancer Lett 2015; 356:937-45; PMID:25444913; http://dx.doi.org/10.1016/j.canlet.2014.11.011
   PubMed Web of Science ®Google Scholar
• Kozaki K, Inazawa J. Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci 2012; 103:837-45; PMID:22320679; http://dx.doi.org/10.1111/j.1349-7006.2012.02236.x
   PubMed Web of Science ®Google Scholar
• Harada K, Baba Y, Ishimoto T. Suppressor microRNA-145 is epigenetically regulated by promoter hypermethylation in esophageal squamous cell carcinoma. Anticancer Res 2015; 35:4617-24; PMID:26254350
   PubMed Web of Science ®Google Scholar
• King CE, Wang L, Winograd R, Madison BB, Mongroo PS, Johnstone CN, Rustgi AK. LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 2011; 30:4185-93; PMID:21625210; http://dx.doi.org/10.1038/onc.2011.131
   PubMed Web of Science ®Google Scholar
• Li F, Li XJ, Qiao L, Shi F, Liu W, Li Y, Dang YP, Gu WJ, Wang XG, Liu W. miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6. Exp Mol Med 2014; 46:e116; PMID:25277211; http://dx.doi.org/10.1038/emm.2014.63
   PubMed Web of Science ®Google Scholar
• Li Y, Sun Z, Zhu Z, Zhang J, Sun X, Xu H. PBX3 is overexpressed in gastric cancer and regulates cell proliferation. Tumour Biol 2014; 35:4363-8; PMID:24375258; http://dx.doi.org/10.1007/s13277-013-1573-6
   PubMed Web of Science ®Google Scholar
• Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, et al. PBX3 is a putative biomarker of aggressive prostate cancer. Int J Cancer 2016; 139(8):1810-20. [ Epub ahead of print]; PMID:27273830; http://dx.doi.org/10.1002/ijc.30220
   PubMed Web of Science ®Google Scholar
• Han HB, Gu J, Ji DB, Li ZW, Zhang Y, Zhao W, Wang LM, Zhang ZQ. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway. World J Gastroenterol 2014; 20:18260-70; PMID:25561793; http://dx.doi.org/10.3748/wjg.v20.i48.18260
   PubMed Web of Science ®Google Scholar
• Chauhan D, Li G, Hideshima T, Podar K, Shringarpure R, Mitsiades C, Munshi N, Yew PR, Anderson KC. Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib/Proteasome inhibitor PS-341. Oncogene 2004; 23:3597-602; PMID:15094775http://dx.doi.org/10.1038/sj.onc.1207458
   PubMed Web of Science ®Google Scholar
• Wong SC, He CW, Chan CM, Chan AK, Wong HT, Cheung MT, Luk LL, Au TC, Chiu MK, Ma BB, et al. Clinical significance of frizzled homolog 3 protein in colorectal cancer patients. PLoS One 2013; 8:e79481; PMID:24255701; http://dx.doi.org/10.1371/journal.pone.0079481
   PubMedGoogle Scholar
• Zhu C, Li J, Cheng G, Zhou H, Tao L, Cai H, Li P, Cao Q, Ju X, Meng X, et al. miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells. Mol Cell Biochem 2013; 379:69-75; PMID:23591597; http://dx.doi.org/10.1007/s11010-013-1628-4
   PubMed Web of Science ®Google Scholar
• Sterenczak KA, Eckardt A, Kampmann A, Willenbrock S, Eberle N, Länger F, Kleinschmidt S, Hewicker-Trautwein M, Kreipe H, Nolte I, et al. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma. BMC Cancer 2014; 14:694; PMID:25245141; http://dx.doi.org/10.1186/1471-2407-14-694
   PubMed Web of Science ®Google Scholar
• Lee J, Ha S, Jung CK, Lee HH. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. Int J Oncol 2015; 46:2431-8; PMID:25845850; http://dx.doi.org/10.3892/ijo.2015.2947
   PubMed Web of Science ®Google Scholar
• Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, Wu J, Chen M, Wu JZ, He X. HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Onco Targets Ther 2015; 8:169-76; PMID:25653540; http://dx.doi.org/10.2147/OTT.S74397
   PubMed Web of Science ®Google Scholar
• Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, Okada Y, D'Armiento J, Chada K. HMGA2 is a driver of tumor metastasis. Cancer Res 2013; 73:4289-99; PMID:23722545; http://dx.doi.org/10.1158/0008-5472.CAN-12-3848
   PubMed Web of Science ®Google Scholar
• Abbott AL, Alvarez-Saavedra E, Miska EA, Lau NC, Bartel DP, Horvitz HR, Ambros V. The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 2005; 9:403-14; PMID:16139228; http://dx.doi.org/10.1016/j.devcel.2005.07.009
   PubMed Web of Science ®Google Scholar
• Tzur G, Israel A, Levy A, Benjamin H, Meiri E, Shufaro Y, Meir K, Khvalevsky E, Spector Y, Rojansky N, et al. Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS One 2009; 4:e7511; PMID:19841744; http://dx.doi.org/10.1371/journal.pone.0007511
   PubMedGoogle Scholar
• Papaioannou G, Inloes JB, Nakamura Y, Paltrinieri E, Kobayashi T. let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc Natl Acad Sci U S A 2013; 110:E3291-300; PMID:23940373; http://dx.doi.org/10.1073/pnas.1302797110
   PubMedGoogle Scholar
• Maller Schulman BR, Liang X, Stahlhut C, DelConte C, Stefani G, Slack FJ. The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure. Cell Cycle 2008; 7:3935-42; PMID:19098426; http://dx.doi.org/10.4161/cc.7.24.7397
   PubMed Web of Science ®Google Scholar
• Rowe RG, Wang LD, Coma S, Han A, Mathieu R, Pearson DS, Ross S, Sousa P, Nguyen PT, Rodriguez A, et al. Developmental regulation of myeloerythroid progenitor function by the Lin28b-let-7-Hmga2 axis. J Exp Med 2016; 213(8):1497-512; PMID:27401346; http://dx.doi.org/10.1084/jem.20151912
   PubMed Web of Science ®Google Scholar
• Metlapally R, Gonzalez P, Hawthorne FA, Tran-Viet KN, Wildsoet CF, Young TL. Scleral micro-RNA signatures in adult and fetal eyes. PLoS One 2013; 8(10):e78984; PMID:24205357; http://dx.doi.org/10.1371/journal.pone.0078984
   PubMed Web of Science ®Google Scholar